Analyst Research

Report Title Price
Provider: Directors Deals Ltd.
$12.00
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Morphosys AG Increases FY 2013 Guidance


Thursday, 24 Oct 2013 01:55pm EDT 

Morphosys AG announced that it has increased its financial guidance for full fiscal year 2013, and expects an EBIT of EUR 7 million to EUR 10 million (up from previously EUR 2 million to EUR 6 million) and revenues at the upper end of the previously communicated guidance range of EUR 74 million to EUR 78 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2013 EBIT of EUR 7.12 million and revenue of EUR 72.87 million. 

Company Quote

86.72
2.13 +2.52%
11:35am EST